Patient segmentation and prioritisation

  • Advised on immediate and distantly related co-morbidities with metabolic disorders

  • Identified the attractive patient pool in terms of economic burden and quality of life (QoL)

  • Made key strategic recommendations, collated news coverage and insights on patient segmentation

  • Assessment and identification of attractive patient segments in metabolic disorders
  • Understanding related co-morbidities with high unmet need, minimum entry barriers and commercial attractiveness
  • Identifying niche patient pools attractive from a reimbursement point of view
  • Conducted secondary-market research for market analysis
    • In-depth understanding of metabolic disorders and associated co-morbidities
    • Prevalence variations for single or multiple co-morbidity overlap
    • Patient journey covering available diagnostic tests and treatment options
  • Viability assessment
    • Severity level of co-morbidities and associated mortality rates
    • Major co-morbidities with a high economic burden
    • Unmet needs, barriers and how to overcome them
  • Key differentiator analysis
    • Trends of co-morbidities in various body mass index (BMI) classes
    • Target patient segments in various BMI classes with clinical significance
    • Attractive geographies for identified conditions


  • Provided research and analysis support to formulate actionable insights
  • Provided data evidence to indicate the need to change clinical guidelines and treatment protocols
  • Assessed regulatory framework for conducting clinical trials for identified conditions
  • Assessed potential end points in patient journey
  • Provided bespoke research support on patient segmentation
  • Helped client ascertain which patient segment or indications to target and the areas on which to focus resources
Thank you for sharing your details

Your file will start downloading automatically

If it does not download within 1 minute,

Share this on